Key points are not available for this paper at this time.
Graves' disease is an autoimmune disorder that induces excessive thyroid hormone production. Thionamides are typically used for treatment but in rare circumstances can result in agranulocytosis. We present the case of a patient who was initiated on methimazole for treatment of Graves' disease, resulting in agranulocytosis, with subsequent Serratia marcescens bacteremia and septic shock.
Bussan et al. (Wed,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: